PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1954
https://www.valueinhealthjournal.com/article/S1098-3015(12)03667-4/fulltext
Title :
PND30 Cost Analysis of Glatiramer Acetate Versus Fingolimod for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03667-4&doi=10.1016/j.jval.2012.08.1954
First page :
A551
Section Title :
Neurological Disorders
Open access? :
No
Section Order :
1441